OSI Systems, Inc. First Quarter 2027 Conference Call - OSI SYSTEMS INC

Explicit Guidance:

• Revenue: Reaffirmed Fiscal 2027 non-GAAP revenue guidance of $1.875 billion to $1.930 billion; expect growth to be strongest in the second half, with Q2 revenues modestly down year-over-year due to prior-year Middle East comparisons and Mexico program headwinds.
• Earnings per Share (EPS): Raised Fiscal 2027 non-GAAP EPS guidance to $11.28–$11.64, representing 9%–12.5% year-over-year growth; the increase is primarily attributed to favorable impact from share repurchases (approx. 7% share count reduction).
• Service Revenue: Expect strong double-digit growth for Fiscal 2027 service revenues, accelerating significantly in Q2 (doubling or more from Q1 levels) and continuing to increase through the second half, driven by products rolling off warranty and increased RF/aviation service activity.
• Cash Flow: Reiterate expectation that full Fiscal 2027 free cash flow will exceed GAAP net income; anticipate strong annual free cash flow conversion driven by declining receivables from the Mexico customer by year-end.
• Margins: Anticipate gross margin expansion over the balance of the fiscal year driven by higher overall revenues and a greater mix of high-margin service revenues; expect stronger operating margins across all divisions (Security, Opto, Healthcare) and the consolidated entity for the remainder of Fiscal 2027.

Business-Segment Outlook:

• Security Division: Expect strong double-digit service revenue growth throughout Fiscal 2027; long-term objective focuses on pairing growth with margin expansion as recurring service revenue increases; record backlog and strong bookings despite Middle East conflict; LA28 Olympic Games expected to serve as a platform for future large venue security opportunities.
• Opto Electronics & Manufacturing: Anticipate continued robust bookings across EMS, select circuit, and optoelectronics lines; expect the division to close quarters with high backlog levels; margins projected to expand as the division continues to grow.
• Healthcare: Revenue expected to decline in the near term due to capital spending constraints; company expects the division to return to growth in upcoming quarters; focus remains on completing the next-generation monitoring platform and improving operational efficiency.
• RF Business: Expect strong recurring revenue growth and continued expansion; currently executing on a $235 million Homeland Defense Over-the-Horizon Radar contract; $90 million in new bookings expected to contribute to 2027 and subsequent years.

Market and Competitive Outlook:

• Demand Trends: Demand remains robust with a 1.4 book-to-bill ratio and $2.1 billion backlog; bookings materializing in diverse geographies as Middle East activity is temporarily impacted; potential long-term upside from conflict-driven security infrastructure requirements.
• Pricing and Mix: Margins may fluctuate based on product/service mix, volume, supply chain costs, FX, and tariffs; long-term margin expansion expected as high-margin service revenue grows as a larger part of the mix.
• Competitive Position: Company maintains dominant market position in specific RF areas with unique offerings regarded favorably by customers; preparing as the official physical screening provider for LA28 to compete for future event security contracts.

Macro / Industry Outlook:

• Geopolitics: Middle East conflict continues to affect activity in the region, causing timing shifts and year-over-year comps; management notes that historically, conflict resolution often leads to increased security orders; potential for further escalation or resolution remains a variable.
• US Government Funding: Expect funding for DHS and "Golden Dome" programs to remain supported as much of the financing was already allocated in the reconciliation bill; waiting on specific CBP orders to be released from existing funding vehicles.
• Supply Chain & Operations: Global supply chain diversification (North America, Europe, Southeast Asia) continues to serve customers well; capacity currently robust with ability to add shifts or facilities if necessary to meet RF business growth.
• Interest Rates: Over 90% of debt is at fixed rates, limiting sensitivity to short-term interest rate increases; reduced borrowing costs expected to continue impacting below-the-line expenses.

Strategic Initiatives:

• M&A and Capital Allocation: Priorities remain organic investment, strategic acquisitions (looking for opportunities that build momentum or increase market penetration), and opportunistic share repurchases; no immediate pressure to acquire, but open to strategic deals.
• Capacity Expansion: RF business has moved into a second new facility; current capacity is sufficient to meet the robust pipeline, with flexibility to add a second shift or additional facilities if required.
• Stock Buybacks: Board authorized an additional $1 million in repurchase authorization in August; Q1 repurchased <del>306,000 shares (</del>$62M); ~773,000 shares remaining available under the program.
• Product Development: Focused on completing the next-generation patient monitoring platform for the Healthcare division to drive future growth.

Risks and Headwinds to Outlook:

• Geopolitical Risks: Timing and magnitude of impact from conflicts in the Middle East and potential escalation could alter revenue recognition timing or future demand.
• Government Procurement: Uncertainty regarding U.S. government funding timing, procurement schedules, and potential legislative shutdowns (e.g., reconciliation bill delays).
• Execution Risks: Actual results could vary due to the timing of backlog conversion, new bookings, cash collections, supply chain disruptions, and tariff implementation.
• Financial Metrics: Guidance excludes potential impairment, restructuring, discrete tax items, and amortization of acquired intangibles; margins may be impacted by unfavorable product mix or supply chain cost fluctuations in the short term.

Management Tone on the Future:

• Confidence: High confidence in the "strong second half" narrative and the ability to convert the record $2.1 billion backlog into revenue; optimistic about the long-term opportunity in the RF business and service revenue growth.
• Caution: Deliberately prudent and conservative regarding Q2 revenue guidance and maintaining the overall FY2027 revenue target despite high backlog, citing geopolitical uncertainty and the need to account for the Middle East comp and Mexico transition.
• Strategic Focus: Emphasis on disciplined execution, converting backlog, improving Healthcare margins, and driving margin expansion via service mix.